placebo for ABT-450

DRUG2 trials

Sponsors

AbbVie, Abbott

Conditions

HCV Infection

Phase 1

Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1

CompletedNCT00850044

AbbVieHCV Infection

Start: 2009-02-28Updated: 2017-11-20

Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

CompletedNCT00931281

AbbottHCV Infection

Start: 2009-06-30Updated: 2010-10-13

Related Papers

Pharmacokinetics and tolerability of paritaprevir, a direct acting antiviral agent for hepatitis C virus treatment, with and without ritonavir in healthy volunteers.

2016-02-2423 citations